Daily Endocrinology Research Analysis
Three standout endocrinology papers span mechanism-to-policy impact: a JCI study uncovers an epigenetic pathway by which SGLT2 inhibition protects kidneys via SAM-driven H3K27 trimethylation and NF-κB repression; a Nature Medicine analysis from India links high-carbohydrate diets to greater diabetes risk and models protein-for-carb substitutions that lower risk; and a JBMR report identifies helix 8 PTH1R variants causing a novel brachydactyly type E syndrome with functional deficits validated in
Summary
Three standout endocrinology papers span mechanism-to-policy impact: a JCI study uncovers an epigenetic pathway by which SGLT2 inhibition protects kidneys via SAM-driven H3K27 trimethylation and NF-κB repression; a Nature Medicine analysis from India links high-carbohydrate diets to greater diabetes risk and models protein-for-carb substitutions that lower risk; and a JBMR report identifies helix 8 PTH1R variants causing a novel brachydactyly type E syndrome with functional deficits validated in cells and mice.
Research Themes
- Metabolic-epigenetic mechanisms of SGLT2 inhibition in kidney protection
- Dietary macronutrient composition and diabetes risk in South Asia
- PTH1R helix 8 variants and skeletal development disorders
Selected Articles
1. SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress.
In SGLT2-deficient mice under diabetogenic stress, renal SAM levels increased and correlated with improved kidney function and repression of NF-κB–related genes via enhanced H3K27 trimethylation. Pharmacologic inhibition of MAT2A (reducing SAM synthesis) abolished kidney protection, positioning SAM-dependent epigenetic remodeling as a key mediator of SGLT2 inhibitor nephroprotection.
Impact: This study identifies a concrete epigenetic pathway linking SGLT2 inhibition to kidney protection, advancing mechanistic understanding beyond hemodynamics. It provides testable biomarkers (SAM, H3K27me3) and targets (MAT2A) for translational studies.
Clinical Implications: Suggests that kidney benefits of SGLT2 inhibitors may be monitored via epigenetic or metabolite signatures (e.g., SAM, H3K27me3 at inflammatory loci). It motivates studies to stratify responders and to explore adjunct therapies that modulate SAM/MAT2A pathways.
Key Findings
- Renal SAM levels increased in SGLT2-deficient mice under high-fat diabetogenic stress and associated with improved kidney function.
- NF-κB pathway gene expression was reduced with concomitant increases in H3K27 trimethylation at these loci.
- Inhibition of MAT2A (SAM synthetase) abrogated the kidney-protective phenotype, implicating SAM production as necessary.
- Injured proximal tubular cells in mice and humans showed reduced MAT2A/MAT2A expression under HFD conditions.
Methodological Strengths
- Multi-system validation across mouse models, human proximal tubular injury contexts, and epigenetic profiling (H3K27me3).
- Causal perturbation via MAT2A inhibition to test necessity of SAM production for kidney protection.
Limitations
- Preclinical mechanistic work; clinical corroboration of SAM/H3K27me3 biomarkers in patients on SGLT2 inhibitors is pending.
- Specificity to diet-induced metabolic stress contexts may limit generalizability to other CKD etiologies.
Future Directions: Prospective human studies to quantify renal SAM and H3K27me3 signatures with SGLT2 inhibitors; evaluate whether MAT2A/SAM modulation augments renoprotection; integrate single-cell epigenomics to map cell-type–specific effects.
Clinically, blockade of renal glucose resorption by sodium-glucose cotransporter 2 (SGLT2) inhibitors slows progression of kidney disease, yet the underlying mechanisms are not fully understood. We hypothesized that altered renal metabolites underlie observed kidney protection when SGLT2 function is lost. S-adenosylmethionine (SAM) levels were increased in kidneys from mice lacking SGLT2 function on a diabetogenic high-fat diet (SPHFD) compared with WT mice fed HFD. Elevated SAM in SPHFD was associated with improved kidney function and decreased expression of NF-κB pathway-related genes. Injured proximal tubular cells that emerged under HFD conditions in WT mice and humans consistently showed reduction in expression of the SAM synthetase Mat2a/MAT2A, while MAT2A inhibition, which reduces SAM production, abrogated kidney protection in SPHFD mice. Histone H3 lysine 27 (H3K27) repressive trimethylation of NF-κB-related genes was increased in SPHFD, consistent with SAM's role as a methyl donor. Our data support a model whereby SGLT2 loss enhances SAM levels within the kidney, leading to epigenetic repression of inflammatory genes and kidney protection under metabolic stress.
2. Dietary profiles and associated metabolic risk factors in India from the ICMR-INDIAB survey-21.
In 18,090 Indian adults, high carbohydrate intake—dominated by refined grains and sugars—was associated with higher odds of newly diagnosed T2D, prediabetes, and obesity. Isocaloric substitution models indicated that replacing carbohydrates with plant, dairy, egg, or fish proteins was linked to lower T2D and prediabetes risk, whereas simply swapping refined cereals for whole wheat/millets without reducing total carbs did not reduce risk.
Impact: Provides nationally representative, policy-relevant evidence that quantity of carbohydrates matters beyond quality swaps, and that targeted macronutrient substitution could reduce diabetes risk in a high-burden setting.
Clinical Implications: Guides dietary counseling toward reducing overall carbohydrates and saturated fat while increasing protein (plant/dairy/egg/fish) in South Asian populations, rather than relying solely on refined-to-whole-grain swaps.
Key Findings
- High total carbohydrate intake was associated with higher odds of newly diagnosed T2D (OR 1.30), prediabetes (OR 1.20), and obesity outcomes.
- Replacing refined cereals with whole wheat or millets without reducing total carbohydrate quantity did not reduce T2D or abdominal obesity risk.
- Isocaloric substitution of carbohydrates with plant, dairy, egg, or fish proteins was associated with lower risks of T2D and prediabetes.
- Indian diets are characterized by high low-quality carbohydrate and saturated fat intake with low protein consumption.
Methodological Strengths
- Large, nationally representative sample with standardized dietary assessment.
- Isocaloric macronutrient substitution modeling to infer practical dietary strategies.
Limitations
- Cross-sectional design limits causal inference; residual confounding possible.
- Dietary intake based on self-report food frequency questionnaires may introduce measurement error.
Future Directions: Randomized feeding trials in South Asian populations testing macronutrient substitution; implementation studies integrating culturally tailored protein diversification while reducing refined carbs and saturated fat.
Rapid dietary transitions in India have been associated with an alarming rise in cardiometabolic diseases. Using data from the national Indian Council of Medical Research-India Diabetes survey (18,090 adults), we examined India's dietary profile and the effect of isocaloric substitution of carbohydrates with other macronutrients on metabolic risk. Indian diets are characterized by high intakes of low-quality carbohydrates (white rice, milled whole grains and added sugar), high levels of saturated fat and low intakes of protein. Compared to those with the least carbohydrate intakes, those with the highest intakes had higher risk of newly diagnosed type 2 diabetes (T2D; odds ratio (OR) = 1.30, 95% confidence interval (CI) = 1.14,1.47), prediabetes (OR = 1.20, 95% CI = 1.06,1.33), generalized obesity (OR = 1.22, 95% CI = 1.07,1.37) and abdominal obesity (OR = 1.15, 95% CI = 1.01, 1.30). Replacing refined cereals with whole wheat or millet flour without decreasing overall carbohydrate quantity was not associated with lower risk for T2D (OR = 0.94, 95% CI = 0.57, 1.56) or abdominal obesity (OR = 1.08, 95% CI = 0.66, 1.76). Modeled isocaloric substitution of carbohydrates for plant, dairy, egg or fish protein was associated with lower likelihood of T2D (ranging from OR = 0.89, 95% CI = 0.83, 0.95-for dairy to OR = 0.91, 95% CI = 0.82, 0.99-egg) and prediabetes (ranging from OR = 0.82, 95% CI = 0.72, 0.92-for dairy to OR = 0.94, 95% CI = 0.89, 0.99-for fish). Public health strategies that reduce overall carbohydrates and saturated fat while increasing intake of plant and dairy proteins could mitigate the risk of metabolic diseases in India.
3. A novel brachydactyly type E syndrome caused by variants in helix 8 of the PTH1R.
Two helix 8 PTH1R variants (p.E469K familial and p.E465K de novo) cause a novel skeletal syndrome featuring brachydactyly type E, mild short stature, and dental anomalies. Functional assays show reduced receptor surface expression and impaired cAMP signaling, and a humanized knock-in mouse carrying p.E469K recapitulates bone changes, implicating helix 8 in PTH1R expression/signaling during development.
Impact: Defines a new genetic skeletal syndrome linked to PTH1R helix 8 with mechanistic validation, refining the genotype–phenotype spectrum and informing genetic diagnosis and counseling.
Clinical Implications: Supports targeted PTH1R sequencing (including helix 8) in patients with brachydactyly type E and dental anomalies; functional deficits suggest limited receptor signaling that may inform future therapeutic strategies.
Key Findings
- Identified PTH1R helix 8 variants p.E469K (familial) and p.E465K (de novo) causing brachydactyly type E, mild short stature, and dental anomalies.
- Both variants reduce PTH1R cell surface expression and impair basal and PTH/PTHrP-stimulated cAMP signaling in cell-based assays.
- Humanized PTH1R mice harboring p.E469K showed increased paw bone mineralization and shortened long bones.
Methodological Strengths
- Integrated human genetics with cellular functional assays and an in vivo humanized knock-in mouse model.
- Variant-specific mechanistic dissection of receptor trafficking and signaling (cAMP).
Limitations
- Small number of human cases; broader prevalence and phenotypic variability remain to be defined.
- Therapeutic implications are inferential; no interventional data yet.
Future Directions: Screen larger cohorts for helix 8 PTH1R variants; map genotype–phenotype correlations; explore pharmacologic chaperones or biased agonists to rescue signaling.
The parathyroid hormone receptor 1 (PTH1R) transmits stimuli provided by parathyroid hormone (PTH) and PTH-related protein (PTHrP) and thus plays key roles in calcium and phosphate homeostasis as well as skeletal development. Variants in PTH1R have been linked to several conditions including Jansen's metaphyseal chondrodysplasia, Blomstrand chondrodysplasia, Primary Failure of Tooth Eruption and Eiken syndrome. Here, we report a novel skeletal phenotype identified in two unrelated families associated with PTH1R variants. The clinical features include brachydactyly type E (BDE), mild short stature, and dental anomalies. A novel heterozygous PTH1R substitution (p.E469K) was identified in affected members of Family 1, while the affected individual from Family 2 had a previously described heterozygous de novo substitution (p.E465K); these two mutated sites lie within helix 8 of the PTH1R. Cell-based assays revealed reduced cell surface expression, as well as impaired basal and PTH- or PTHrP-induced cAMP signaling responses for both mutants, as compared to WT-PTH1R. Introduction of the p.E469K substitution into humanized PTH1R mice resulted in mildly increased mineralization of bones in the paws as well as shortening of long bones. Our findings demonstrate a new skeletal phenotype associated with PTH1R variants and suggest that helix 8 of the receptor contributes to PTH1R expression and/or signaling during bone development. The parathyroid hormone receptor 1 (PTH1R) is essential for calcium signaling and bone development. Changes in the PTH1R gene and/or protein affect its ability to function properly thus leading to disease. In a large family and an unrelated case, we identified changes in the PTH1R gene as the cause of short fingers and toes (Brachydactyly type E; BDE), short stature, and dental abnormalities, which is novel for PTH1R variants. Through experiments in cells and mice, we showed that the altered PTH1R protein affects cellular signaling and function, and leads to abnormal bone development. This work improves the understanding of PTH1R-related signaling and disease.